The role of protein post-translational modifications in prostate cancer.


Journal

PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425

Informations de publication

Date de publication:
2024
Historique:
received: 20 03 2024
accepted: 27 06 2024
medline: 16 8 2024
pubmed: 16 8 2024
entrez: 16 8 2024
Statut: epublish

Résumé

Involving addition of chemical groups or protein units to specific residues of the target protein, post-translational modifications (PTMs) alter the charge, hydrophobicity, and conformation of a protein, which in turn influences protein function, protein-protein interaction, and protein aggregation. These alterations, which include phosphorylation, glycosylation, ubiquitination, methylation, acetylation, lipidation, and lactylation, are significant biological events in the development of cancer, and play vital roles in numerous biological processes. The processes behind essential functions, the screening of clinical illness signs, and the identification of therapeutic targets all depend heavily on further research into the PTMs. This review outlines the influence of several PTM types on prostate cancer (PCa) diagnosis, therapy, and prognosis in an effort to shed fresh light on the molecular causes and progression of the disease.

Identifiants

pubmed: 39148683
doi: 10.7717/peerj.17768
pii: 17768
pmc: PMC11326433
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e17768

Informations de copyright

©2024 Hao et al.

Déclaration de conflit d'intérêts

The authors declare there are no competing interests.

Auteurs

Yinghui Hao (Y)

Central Laboratory, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, China.

Chenqiong Gu (C)

Central Laboratory, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, China.

Wenfeng Luo (W)

Central Laboratory, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, China.

Jian Shen (J)

Central Laboratory, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, China.

Fangmei Xie (F)

Central Laboratory, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, China.

Ying Zhao (Y)

Central Laboratory, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, China.

Xiaoyu Song (X)

Central Laboratory, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, China.

Zeping Han (Z)

Central Laboratory, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, China.

Jinhua He (J)

Central Laboratory, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, China.
Rehabilitation Medicine Institute of Panyu District, Guangzhou, Guangdong, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH